欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0356/002
药品名称
Certican
活性成分
Everolimus 0.5 mg
剂型
Tablet
上市许可持有人
Novartis Sverige AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
Belgium (BE)
Luxembourg (LU)
Iceland (IS)
Austria (AT)
Certican 0,5 mg - Tabletten
France (FR)
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
Norway (NO)
Finland (FI)
Poland (PL)
Lithuania (LT)
Certican 0,5mg tabletės
Estonia (EE)
Hungary (HU)
Cyprus (CY)
Slovenia (SI)
Bulgaria (BG)
Certican
Romania (RO)
CERTICAN 0,50 mg comprimate
Croatia (HR)
许可日期
2003/12/02
最近更新日期
2025/01/08
药物ATC编码
L04AA18 everolimus
申请类型
TypeLevel1:
New Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Full Dossier Article 4.8 Di 65/65
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_0356_002_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0356_002_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_0356_002_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_0356_002_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase